ETH-155036: Novel Flt3/CSF1R/CDK6 Inhibitor
- One compound for simultaneous inhibition of three significant pathways (CSF1R, FLT3 and CDK6) involved in AML and other tumor development
- Induce synergistic enhancement in killing tumor cells
- Reduce the chances of acquistion of FLT3 resistance mutations
- Lead to more durable clinical response
Source: Am J Blood Res. 2011 175-189
